In the contest of BReast CAncer gene (BRCA)-mutated cancers with compromised HR repair, low CCDC6 protein levels can increase lung cancers cells’ sensitivity to olaparib alone or synergize with chemotherapy. The gene discussed is CCDC6; the disease is lung carcinoma.